Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patz, E. F.
Right arrow Articles by Goodman, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patz, E. F., Jr
Right arrow Articles by Goodman, P. C.

Radiology, Vol 191, 379-382, Copyright © 1994 by Radiological Society of North America


ARTICLES

Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose

EF Patz Jr, VJ Lowe, JM Hoffman, SS Paine, LK Harris and PC Goodman
Department of Radiology, Duke University Medical Center, Durham, NC 27710.

PURPOSE: To assess positron emission tomography (PET) with 2-[fluorine- 18]-2-deoxy-D-glucose (FDG) in the differentiation of recurrent bronchogenic carcinoma from fibrosis after therapy. MATERIALS AND METHODS: Any patient treated for bronchogenic carcinoma who had a residual chest radiographic abnormality was eligible. Forty-three patients (mean age, 63.5 years) participated. Chest radiographs and thoracic computed tomographic scans helped localize the abnormality prior to PET. Semiquantitative analysis was performed on FDG PET images with calculated standardized uptake ratios (SURs). Sensitivity, specificity, and confidence intervals for recurrent disease were determined. RESULTS: Thirty-five patients had recurrent or persistent tumor (median SUR, 7.6; range, 1.9-18.7). Eight patients had fibrosis but no evidence of disease (SUR, 1.6; range, 0.6-2.4). The sensitivity for detecting recurrent tumor (SUR > 2.5) was 97.1%, and specificity was 100%. The SUR for recurrent tumor was statistically significantly higher than for fibrosis (P = .0001). CONCLUSION: FDG PET accurately helps differentiate recurrent bronchogenic carcinoma from fibrosis.


This article has been cited by other articles:


Home page
JNMHome page
B. Goudarzi, H. A. Jacene, and R. L. Wahl
Diagnosis and Differentiation of Bronchioloalveolar Carcinoma from Adenocarcinoma with Bronchioloalveolar Components with Metabolic and Anatomic Characteristics Using PET/CT
J. Nucl. Med., October 1, 2008; 49(10): 1585 - 1592.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. Rubins, M. Unger, and G. L. Colice
Follow-up and Surveillance of the Lung Cancer Patient Following Curative Intent Therapy: ACCP Evidence-Based Clinical Practice Guideline (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 355S - 367S.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
O. Israel and A. Kuten
Early Detection of Cancer Recurrence: 18F-FDG PET/CT Can Make a Difference in Diagnosis and Patient Care
J. Nucl. Med., January 1, 2007; 48(1_suppl): 28S - 35S.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. E. Juweid and B. D. Cheson
Positron-Emission Tomography and Assessment of Cancer Therapy
N. Engl. J. Med., February 2, 2006; 354(5): 496 - 507.
[Full Text] [PDF]


Home page
JCOHome page
L. K. Shankar and D. C. Sullivan
Functional Imaging in Lung Cancer
J. Clin. Oncol., May 10, 2005; 23(14): 3203 - 3211.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Z. Keidar, N. Haim, L. Guralnik, M. Wollner, R. Bar-Shalom, A. Ben-Nun, and O. Israel
PET/CT Using 18F-FDG in Suspected Lung Cancer Recurrence: Diagnostic Value and Impact on Patient Management
J. Nucl. Med., October 1, 2004; 45(10): 1640 - 1646.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
Y. W. Choi, R. F. Munden, J. J. Erasmus, K. Joo Park, W. K. Chung, S. C. Jeon, and C.-K. Park
Effects of Radiation Therapy on the Lung: Radiologic Appearances and Differential Diagnosis
RadioGraphics, July 1, 2004; 24(4): 985 - 997.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
T. Aoki, Y. Nagata, Y. Negoro, K. Takayama, T. Mizowaki, M. Kokubo, N. Oya, M. Mitsumori, and M. Hiraoka
Evaluation of Lung Injury after Three-dimensional Conformal Stereotactic Radiation Therapy for Solitary Lung Tumors: CT Appearance
Radiology, January 1, 2004; 230(1): 101 - 108.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. V. Gonzalez-Stawinski, A. Lemaire, F. Merchant, E. O'Halloran, R. E. Coleman, D. H. Harpole, and T. A. D'Amico
A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer
J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1900 - 1904.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
N Raghunand, R A Gatenby, and R J Gillies
Microenvironmental and cellular consequences of altered blood flow in tumours
Br. J. Radiol., December 1, 2003; 76(suppl_1): S11 - S22.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. A. Gatenby and E. T. Gawlinski
The Glycolytic Phenotype in Carcinogenesis and Tumor Invasion: Insights through Mathematical Models
Cancer Res., July 15, 2003; 63(14): 3847 - 3854.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
L. Kostakoglu, H. Agress Jr, and S. J. Goldsmith
Clinical Role of FDG PET in Evaluation of Cancer Patients
RadioGraphics, March 1, 2003; 23(2): 315 - 340.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. P. Graeter, D. Hellwig, K. Hoffmann, D. Ukena, C.-M. Kirsch, and H.-J. Schafers
Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy
Ann. Thorac. Surg., January 1, 2003; 75(1): 231 - 236.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. L. Colice, J. Rubins, and M. Unger
Follow-up and Surveillance of the Lung Cancer Patient Following Curative-Intent Therapy
Chest, January 1, 2003; 123(1_suppl): 272S - 283S.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. A. D'Amico, T. Z. Wong, D. H. Harpole, S. D. Brown, and R. E. Coleman
Impact of computed tomography-positron emission tomography fusion in staging patients with thoracic malignancies
Ann. Thorac. Surg., July 1, 2002; 74(1): 160 - 163.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. Lee, J. M. Aronchick, and A. Alavi
Accuracy of F-18 Fluorodeoxyglucose Positron Emission Tomography for the Evaluation of Malignancy in Patients Presenting With New Lung Abnormalities : A Retrospective Review
Chest, December 1, 2001; 120(6): 1791 - 1797.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. J. Hicks, V. Kalff, M. P. MacManus, R. E. Ware, A. F. McKenzie, J. P. Matthews, and D. L. Ball
The Utility of 18F-FDG PET for Suspected Recurrent Non-Small Cell Lung Cancer After Potentially Curative Therapy: Impact on Management and Prognostic Stratification
J. Nucl. Med., November 1, 2001; 42(11): 1605 - 1613.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps
A Tabulated Summary of the FDG PET Literature
J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93.
[Full Text] [PDF]


Home page
Eur Respir JHome page
J.F. Vansteenkiste and S.G. Stroobants
The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
Eur. Respir. J., April 1, 2001; 17(4): 802 - 820.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
G.-U. Hung, Y.-C. Shiau, S.-C. Tsai, Y.-J. Ho, C.-H. Kao, and R.-F. Yen
Differentiation of Radiographically Indeterminate Solitary Pulmonary Nodules with [18F]Fluoro-2-deoxyglucose Positron Emission Tomography
Jpn. J. Clin. Oncol., February 1, 2001; 31(2): 51 - 54.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
V. Kalff, R. J. Hicks, M. P. MacManus, D. S. Binns, A. F. McKenzie, R. E. Ware, A. Hogg, and D. L. Ball
Clinical Impact of 18F Fluorodeoxyglucose Positron Emission Tomography in Patients With Non-Small-Cell Lung Cancer: A Prospective Study
J. Clin. Oncol., January 1, 2001; 19(1): 111 - 118.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. M. Goo, J.-G. Im, K.-H. Do, J. S. Yeo, J. B. Seo, H. Y. Kim, and J.-K. Chung
Pulmonary Tuberculoma Evaluated by Means of FDG PET: Findings in 10 Cases
Radiology, July 1, 2000; 216(1): 117 - 121.
[Abstract] [Full Text]


Home page
RadioGraphicsHome page
S. J. Skehan, A. L. Brown, M. Thompson, J. E. M. Young, G. Coates, and C. Nahmias
Imaging Features of Primary and Recurrent Esophageal Cancer at FDG PET
RadioGraphics, May 1, 2000; 20(3): 713 - 723.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Carretta, C. Landoni, G. Melloni, G. L. Ceresoli, A. Compierchio, F. Fazio, and P. Zannini
18-FDG positron emission tomography in the evaluation of malignant pleural diseases - a pilot study
Eur. J. Cardiothorac. Surg., April 1, 2000; 17(4): 377 - 383.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
R. E. Coleman, C. M. Laymon, and T. G. Turkington
FDG Imaging of Lung Nodules: A Phantom Study Comparing SPECT, Camera-based PET, and Dedicated PET
Radiology, March 1, 1999; 210(3): 823 - 828.
[Abstract] [Full Text]


Home page
ThoraxHome page
V. J Lowe and K. S Naunheim
Current role of positron emission tomography in thoracic oncology
Thorax, August 1, 1998; 53(8): 703 - 712.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
V. J. Lowe and K. S. Naunheim
Positron Emission Tomography in Lung Cancer
Ann. Thorac. Surg., June 1, 1998; 65(6): 1821 - 1829.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1994 by the Radiological Society of North America.